Cargando…

Novel insights into mutual regulation between N(6)-methyladenosine modification and LncRNAs in tumors

N(6)-methyladenosine (m(6)A), one of the most common RNA methylation modifications, has emerged in recent years as a new layer of the regulatory mechanism controlling gene expression in eukaryotes. As a reversible epigenetic modification, m(6)A not only occurs on mRNAs but also on Long non-coding RN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nan, Sun, Yifei, Mei, Zongqin, He, Zuoshun, Gu, Shiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291820/ https://www.ncbi.nlm.nih.gov/pubmed/37365581 http://dx.doi.org/10.1186/s12935-023-02955-1

Ejemplares similares

Emerging Mutual Regulatory Roles between m(6)A Modification and microRNAs
por: Mei, Zongqin, et al.
Publicado: (2023)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
por: Gao, Chen, et al.
Publicado: (2022)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
por: Song, Danjun, et al.
Publicado: (2023)

Comprehensive analysis of differences of N(6)-methyladenosine of lncRNAs between atrazine-induced and normal Xenopus laevis testis
por: Qi, Xuejie, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
por: Lin, Hong, et al.
Publicado: (2022)

Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients
por: Chen, Yuqing, et al.
Publicado: (2023)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
por: Xu, Shuyu, et al.
Publicado: (2022)

Insights into the Functions of LncRNAs in Drosophila
por: Li, Keqin, et al.
Publicado: (2019)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

N6-Methyladenosine (m(6)A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

The role of M(6)A modification in the regulation of tumor-related lncRNAs
por: Lan, Yufei, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
por: Huang, Xin, et al.
Publicado: (2022)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

Insights into lncRNAs in Alzheimer’s disease mechanisms
por: Li, Dingfeng, et al.
Publicado: (2020)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

LncRNAs and Chromatin Modifications Pattern m(6)A Methylation at the Untranslated Regions of mRNAs
por: Vaasjo, Lee O.
Publicado: (2022)

The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers
por: He, Liujia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6iltpddq57o5l85uvannctupkq